Tag: immunotherapy

Medicine of the Future

UCSF has a long history of pioneering biomedical research and a bold vision for advancing science and seeking new ways to improve health care delivery nationwide. But, what does that actually mean in the near future and beyond?

This new series, part of the popular Mini Medical School for the Public, takes you inside the work of UCSF scientists to learn what the next decade may bring to the world of medicine. Hailing from a wide spectrum of disciplines, each explores a different topic that has the potential to impact the future of healthcare.

UCSF was the only medical school to be ranked in the top five in the nation in both research and primary care by US News and World Report, ranking fifth in biomedical research and third in primary care education. UCSF was also the only medical school ranked in the top five in all eight of the specialty areas covered by the survey in 2019.

Browse more programs in Next: UCSF Scientists Outline What’s To Come .

Prostate Cancer

Prostate cancer is the most common cancer among men in the United States. The good news is that it is treatable in the early stages. This series of experts in the field is designed for patients, families, caregivers, health care providers and all those interested in information and tools to make informed decisions about treatment.

This event was presented by the California Prostate Cancer Coalition and the UCSF Helen Diller Family Comprehensive Cancer Center

Topics include:

• Prostate Cancer Basics
• Genetics and Genomics
• Immunology
• Clinical Trials
• ABCs of Androgen Deprivation Therapy
• Low-Risk Disease and Active Surveillance
• Treatment of Metastatic and Non-Metastatic Disease
• Systemic Therapy
• Imaging
• Diet and Exercise
• Managing Side Effects
• Access to Care
• Intimacy and Sexual Function

Browse more programs in Prostate Cancer Patient Conference.

Leading Cancer Experts and Advances in Care

8232Cancer is a major public health problem worldwide and is the second leading cause of death in the United States. In 2016, an estimated 1,685,210 new cases of cancer will be diagnosed in the United States and 595,690 people will die from the disease. But the number of people living beyond a cancer diagnosis is rising every year as medical knowledge increases.

Join the UCSF Helen Diller Family Comprehensive Cancer Center’s team for a series of discussions highlighting the latest advances in cancer research by UCSF’s distinguished physicians and scientists.

Engineering Immune Cells to Recognize and Kill Cancer
Find out how scientists are using immune proteins to mobilize immune cells to fight cancer.

Preventing Cancer: Genetics, Lifestyle, and Environment
Genetic testing, expanded screening, along with behavioral and lifestyle changes, may be the key.

Immunotherapy: Unleashing the Body’s Natural Defense Systems to Fight Cancer
Learn how immunotherapy research is leading to more precise treatments based on individual biology, tumors, and immune system response.

Personalizing Cancer Care and Treatment
Find out how genome-based analysis is providing critical information about the precise cancer type and giving clues about which therapy may be effective.

Patient-Centered Care in the 21st Century
What does patient-centered care look like in practice? How does it differ from the health care that most of us receive? What will it mean for patient health?